Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license
Long QT Syndrome 2, as genome-wide studies have reported it: 29 positions from 1 study. Built from the GWAS Catalog's records and rebuilt when a new position is reported; the figures are the studies'.
Genome-wide studies have so far placed 29 positions on Long QT Syndrome 2, from 1 study; the GWAS Catalog files the condition as "Long QT syndrome 2". MyGeneLog's code assembles this page from those records and rebuilds it when a new position is reported — nothing here was written by hand, and nothing here goes beyond what the records say.
A study. The 29 positions on this page from it: rs121912504 (KCNH2), rs121912505 (KCNH2), rs121912506 (KCNH2), rs121912507 (KCNH2), rs121912508 (KCNH2), rs121912509 (KCNH2), rs121912510 (KCNH2), rs121912511 (KCNH2), and 21 more.
The catalogue maps the 29 positions to 1 gene: KCNH2. That mapping says where a position sits, in a gene or beside one — not what it does. For what each study measured, follow its citation above.
Read this page as a list of findings about Long QT Syndrome 2, not as an account of it. Each finding is a position that a genome-wide study linked to the condition across a population; the page adds no description, no prevalence and no advice, because the records hold none. The variant pages linked above give each study's record for its position, and ClinVar's where one exists.
A genotype does not diagnose Long QT Syndrome 2; a clinician does. No guideline uses the 29 variants on this page to predict it, screen for it or confirm it.
Everything here comes from population-level association records, put together by code. Those records compare groups of people; they do not examine anyone, and they give no guidance on care. For symptoms, testing or treatment, ask a clinician.
Databases, guidelines and references
Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license
Long QT Syndrome 2. MyGeneLog™. https://www.mygenelog.com/conditions/long-qt-syndrome-2
Long QT Syndrome 2 is the condition the GWAS Catalog files under "Long QT syndrome 2". This page does not define it in its own words; it lists what genome-wide studies have reported: 29 positions from 1 study, with each study's sample and citation.
Genome-wide studies have reported 29 associated positions. Each common variant has a small effect, and an association in a population is not a cause in any one person.
The positions lie in or near 1 gene: KCNH2. A mapped gene is the catalogue's location for a position, not a mechanism.
No. They are population-level findings of small effect. Long QT Syndrome 2 is diagnosed by a clinician, and no guideline uses a genotype to predict it.
Free to reuse, non-commercially. This page's text is original writing from freely-available research, licensed CC BY-NC 4.0 — share and adapt it with attribution to MyGeneLog™; commercial use is licensed. It's general research-derived information, not medical advice or a diagnosis — see Terms of Use.